We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SITM:NASDAQSiTime Corporation Analysis

Data as of 2026-09-01 - not real-time

$565.42

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind SiTime Corporation is bullish at $565.42, with short-term averages leading the long-term ones. Across the trailing 30 sessions it gained 1.8%. Relative strength is 43.2 — neutral — and the MACD signal is bearish. Price has been bracketed by support at $543.12 and resistance at $762.65.
Multiples put this in overvalued territory: 912.0 times earnings against the sector's 35.8. The average analyst target implies 52.6% above today's level. Revenue is growing at 126.5% on a 3.0% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 110.2%, a beta of 2.85 and a maximum drawdown of 48.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.

Top Market Events

SiTime is set to report Q2 results on Aug.Yahoo Finance26dSiTime Corporation SITM Q2 FY2026 earnings call transcriptSiTime delivered Q2 2026 revenue of $157.Yahoo Finance25dSiTime Corp SITM Q2 2026 Earnings Call Highlights: Revenue Soars 127% as AI and TPD .

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 494.19
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 912.0 versus sector average of 35.8
  • Trading above the 200-day average of 494.19

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 912.0 versus sector average of 35.8
  • Analyst targets imply +52.6% versus the current price
  • Revenue growth of +126.5%

Key Metrics & Analysis

Financial Health

Revenue Growth126.50%
Profit Margin3.01%
P/E Ratio912.0
ROE1.33%
ROA-0.03%
Debt/Equity129.42
P/B Ratio14.6
Op. Cash Flow$127.7M
Free Cash Flow$24.7M
Industry P/E35.8

Technical Analysis

TrendBullish
RSI43.2
Support$543.12
Resistance$762.65
MA 20$636.67
MA 50$620.13
MA 200$494.19
MACDBearish
VolumeDecreasing
Fear & Greed Index94.79

Valuation

Fair Value$48.53
Target Price$862.78
Upside/Downside52.59%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta2.85
Volatility110.16%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.